Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections
- 1 November 1996
- journal article
- clinical trial
- Published by Springer Nature in Infection
- Vol. 24 (6) , 473-479
- https://doi.org/10.1007/bf01713053
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgeryJournal of Antimicrobial Chemotherapy, 1995
- Antibiotic monotherapy with meropenem in the surgical management of intra-abdominal infectionsJournal of Antimicrobial Chemotherapy, 1995
- Pharmacokinetics of meropenem in patients with intra-abdominal infectionsAntimicrobial Agents and Chemotherapy, 1994
- Wound and Intraabdominal Infections: Microbiological Considerations and Approaches to TreatmentClinical Infectious Diseases, 1993
- A Microbiological Comparison between Acute and Complicated AppendicitisClinical Infectious Diseases, 1992
- Results of a Multicenter Trial Comparing Imipenem/Cilastatin to Tobramycin/Clindamycin for Intra-abdominal InfectionsAnnals of Surgery, 1990
- In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase IAntimicrobial Agents and Chemotherapy, 1989
- In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidime against clinical isolates from West GermanyJournal of Antimicrobial Chemotherapy, 1989
- Beta-Lactam AntibioticsNew England Journal of Medicine, 1988
- Imipenem/Cilastatin in the Treatment of Intraabdominal Infections: A Review of Worldwide ExperienceClinical Infectious Diseases, 1985